Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0VB3P
|
|||
| Drug Name |
PMID26924192-Compound-33
|
|||
| Drug Type |
Small molecular drug
|
|||
| Company |
KYORIN PHARMACEUTICAL CO., LTD
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C34H43N7O3
|
|||
| Canonical SMILES |
CCOC1=C(C=CC(=C1)C(=O)N2CCC(CC2)N3CCCN(CC3)C)NC4=NC=C5C(=C4)N(C6=CC=CC=C6C(=O)N5C)C
|
|||
| InChI |
1S/C34H43N7O3/c1-5-44-31-21-24(33(42)41-17-13-25(14-18-41)40-16-8-15-37(2)19-20-40)11-12-27(31)36-32-22-29-30(23-35-32)39(4)34(43)26-9-6-7-10-28(26)38(29)3/h6-7,9-12,21-23,25H,5,8,13-20H2,1-4H3,(H,35,36)
|
|||
| InChIKey |
YZJHEYIGGRFZOH-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Bromodomain-containing protein 4 (BRD4) | Target Info | Inhibitor | [1] |
| Extracellular signal-regulated kinase 5 (ERK5) | Target Info | Inhibitor | [1] | |
| Target's Patent Info | Bromodomain-containing protein 4 (BRD4) | Target's Patent Info | [1] | |
| Extracellular signal-regulated kinase 5 (ERK5) | Target's Patent Info | [1] | ||
| WikiPathways | Chemical Compounds to monitor Proteins | |||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | BET inhibitors in cancer therapeutics: a patent review.Expert Opin Ther Pat. 2016;26(4):505-22. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.